Home › Funds › Bridgewater Associates › ABBV
Bridgewater Associates position in ABBV
ABBVIE INC · Health Care
Latest position (Q2 2026)11.78K sh
Reported value held$2.96M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 75.10K | $8.10M | New |
| Q4 2021 | 41.85K | $5.67M | Reduce |
| Q1 2022 | 75.52K | $12.24M | Add |
| Q2 2022 | 81.85K | $12.54M | Add |
| Q3 2022 | 212.75K | $28.55M | Add |
| Q4 2022 | 30.10K | $4.86M | Reduce |
| Q1 2023 | 411.43K | $65.57M | Add |
| Q2 2023 | 634.30K | $85.46M | Add |
| Q3 2023 | 575.96K | $85.85M | Reduce |
| Q4 2023 | 606.89K | $94.05M | Add |
| Q1 2024 | 449.78K | $81.90M | Reduce |
| Q2 2024 | 288.52K | $49.49M | Reduce |
| Q3 2024 | 204.57K | $40.40M | Reduce |
| Q4 2024 | 286.36K | $50.89M | Add |
| Q1 2025 | 104.95K | $21.99M | Reduce |
| Q1 2025 | 104.95K | $21.99M | Reduce |
| Q2 2025 | 598.29K | $111.05M | Add |
| Q2 2025 | 598.29K | $111.05M | Add |
| Q3 2025 | 260.69K | $60.36M | Reduce |
| Q4 2025 | 14.21K | $3.25M | Reduce |
| Q1 2026 | 30.36K | $6.60M | Add |
| Q2 2026 | 11.78K | $2.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABBV
- Vanguard Group 180.78M sh · $41.31B · Q4 2025
- BlackRock Inc 149.49M sh · $37.62B · Q2 2026
- Geode Capital Management 47.00M sh · $11.81B · Q2 2026
- Morgan Stanley 38.90M sh · $9.79B · Q2 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Norges Bank Investment Management 25.55M sh · $6.43B · Q2 2026
- Bank of America Corp 21.24M sh · $5.34B · Q2 2026
- Fidelity Management & Research (FMR) 20.77M sh · $5.23B · Q2 2026
- Northern Trust Corp 20.56M sh · $5.17B · Q2 2026
- Franklin Resources 19.93M sh · $5.01B · Q2 2026
- Capital World Investors 19.18M sh · $4.83B · Q2 2026
- Charles Schwab Investment Management 12.91M sh · $3.25B · Q2 2026